CUSIP 30054Y107COM SHSEVMNQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
59 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Eqt Fund Management S.A R.L. | 4.93M | $84.40M | +4.93M | New |
| 2 | Ra Capital Management, L.P. | 3.46M | $59.21M | +3.46M | New |
| 3 | Pivotal Bioventure Partners Investment Advisor LLC | 1.93M | $32.99M | +1.93M | New |
| 4 | Andera Partners | 1.90M | $32.48M |
| +1.90M |
| New Position |
| 5 | Nan Fung Group Holdings Ltd | 1.44M | $24.67M | +1.44M | New |
| 6 | Jpmorgan Chase & Co | 1.31M | $22.41M | +1.31M | New |
| 7 | Rtw Investments, LP | 1.28M | $21.98M | +1.28M | New |
| 8 | Symbiosis Capital Partners, LLC | 1.28M | $21.93M | +1.28M | New Position |
| 9 | Marshall Wace, LLP | 988.2K | $16.92M | +988.2K | New |
| 10 | Eventide Asset Management, LLC | 961.5K | $16.46M | +961.5K | New |
See every fund holding Evommune Inc, with full quarter-over-quarter share changes.
Unlock all holders